Friday, May 12, 2017

CPT 93000, 93005, 93010 (EKG) Lists of Payable/Covered Diagnosis and Applicable Modifiers


93000  Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report
93010  Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only
93005  Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report

Code Description

Multiple electrodes are placed on a patient's chest to record the electrical activity of the heart. A physician interprets the findings. Report 93000 for the combined technical and professional components of an ECG; 93005 for the technical component only; and 93010 for the professional component only.

Instructions and coding tips

Add a 25 modifier to your E&M service when billing in conjunction with an EKG 93000, 93005, 93010 CPT.

Use Modifier XS for 93000 when billed with 93015.
  • Excludes Acoustic cardiography (93799)
  • Excludes ECG monitoring (99354-99360 [99415, 99416])
  • Excludes ECG with 64 or more leads, graphic presentation, and analysis (0178T-0180T)
  • Excludes Echocardiography (93303-93350)
  • Excludes Use of these codes for the review of telemetry monitoring strips
  • Includes Specific order for the service, a separate written and signed report, and documentation of medical necessity
List of Payable/Covered Diagnosis:

A02.1 Salmonella sepsis
A18.84 Tuberculosis of heart
A22.7 Anthrax sepsis
A26.7 Erysipelothrix sepsis
A32.7 Listerial sepsis
A40.0 Sepsis due to streptococcus, group A
A40.9 Streptococcal sepsis, unspecified
A41.01 Sepsis due to Methicillin susceptible Staphylococcus aureus
A41.9 Sepsis, unspecified organism
A42.7 Actinomycotic sepsis
A54.86 Gonococcal sepsis
A74.81 Chlamydial peritonitis
A74.9 Chlamydial infection, unspecified
B33.3 Retrovirus infections, not elsewhere classified
B34.8 Other viral infections of unspecified site
B37.7 Candidal sepsis
B97.0 Adenovirus as the cause of diseases classified elsewhere
B97.89 Other viral agents as the cause of diseases classified elsewhere
E00.0 Congenital iodine-deficiency syndrome, neurological type
E03.4 Atrophy of thyroid (acquired)
E03.8 Other specified hypothyroidism
E07.1 Dyshormogenetic goiter
E07.89 Other specified disorders of thyroid
E07.9 Disorder of thyroid, unspecified
E08.51 Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy without gangrene
E08.52 Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy with gangrene
E09.51 Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy without gangrene
E09.52 Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy with gangrene
E10.10 Type 1 diabetes mellitus with ketoacidosis without coma
E13.9 Other specified diabetes mellitus without complications
E35 Disorders of endocrine glands in diseases classified elsewhere
E84.0 Cystic fibrosis with pulmonary manifestations
E84.9 Cystic fibrosis, unspecified
E85.1 Neuropathic heredofamilial amyloidosis
E85.8 Other amyloidosis
E85.9 Amyloidosis, unspecified
E86.0 Dehydration
E86.9 Volume depletion, unspecified
E87.0 Hyperosmolality and hypernatremia
E87.1 Hypo-osmolality and hyponatremia
E87.2 Acidosis
E87.3 Alkalosis
E87.4 Mixed disorder of acid-base balance
E87.5 Hyperkalemia
E87.6 Hypokalemia
E87.70 Fluid overload, unspecified
E87.79 Other fluid overload
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified
E89.0 Postprocedural hypothyroidism
G45.9 Transient cerebral ischemic attack, unspecified
G90.01 Carotid sinus syncope
G90.09 Other idiopathic peripheral autonomic neuropathy
G90.2 Horner's syndrome
G90.8 Other disorders of autonomic nervous system
G90.9 Disorder of the autonomic nervous system, unspecified
G93.3 Postviral fatigue syndrome
I00 Rheumatic fever without heart involvement
I02.9 Rheumatic chorea without heart involvement
I05.0 Rheumatic mitral stenosis
I09.9 Rheumatic heart disease, unspecified
I10 Essential (primary) hypertension
I15.9 Secondary hypertension, unspecified
I20.0 Unstable angina
I25.9 Chronic ischemic heart disease, unspecified
I26.01 Septic pulmonary embolism with acute cor pulmonale
I28.9 Disease of pulmonary vessels, unspecified
I30.0 Acute nonspecific idiopathic pericarditis
I52 Other heart disorders in diseases classified elsewhere
I67.0 Dissection of cerebral arteries, nonruptured
I67.841 Reversible cerebrovascular vasoconstriction syndrome
I67.848 Other cerebrovascular vasospasm and vasoconstriction
I67.89 Other cerebrovascular disease
I70.0 Atherosclerosis of aorta
I75.89 Atheroembolism of other site
I77.0 Arteriovenous fistula, acquired
I79.8 Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere
I97.0 Postcardiotomy syndrome
I97.191 Other postprocedural cardiac functional disturbances following other surgery
I97.710 Intraoperative cardiac arrest during cardiac surgery
I97.791 Other intraoperative cardiac functional disturbances during other surgery
I97.88 Other intraoperative complications of the circulatory system, not elsewhere classified
I97.89 Other postprocedural complications and disorders of the circulatory system, not elsewhere classified
J20.3 Acute bronchitis due to coxsackievirus
J20.7 Acute bronchitis due to echovirus
J95.4 Chemical pneumonitis due to anesthesia
J95.5 Postprocedural subglottic stenosis
J95.859 Other complication of respirator [ventilator]
J95.89 Other postprocedural complications and disorders of respiratory system, not elsewhere classified
M05.00 Felty's syndrome, unspecified site
M06.9 Rheumatoid arthritis, unspecified
M08.00 Unspecified juvenile rheumatoid arthritis of unspecified site
M08.09 Unspecified juvenile rheumatoid arthritis, multiple sites
M08.20 Juvenile rheumatoid arthritis with systemic onset, unspecified site
M08.99 Juvenile arthritis, unspecified, multiple sites
M12.00 Chronic postrheumatic arthropathy [Jaccoud], unspecified site
M12.09 Chronic postrheumatic arthropathy [Jaccoud], multiple sites
M1A.19X1 Lead-induced chronic gout, multiple sites, with tophus (tophi)
M30.0 Polyarteritis nodosa
M35.1 Other overlap syndromes
M35.5 Multifocal fibrosclerosis
M35.8 Other specified systemic involvement of connective tissue
M36.0 Dermato(poly)myositis in neoplastic disease
M36.8 Systemic disorders of connective tissue in other diseases classified elsewhere
M79.601 Pain in right arm
M79.676 Pain in unspecified toe(s)
N26.2 Page kidney
O74.2 Cardiac complications of anesthesia during labor and delivery
O89.1 Cardiac complications of anesthesia during the puerperium
P29.3 Persistent fetal circulation
Q20.0 Common arterial trunk
Q20.8 Other congenital malformations of cardiac chambers and connections
Q20.9 Congenital malformation of cardiac chambers and connections, unspecified
Q21.0 Ventricular septal defect
Q21.9 Congenital malformation of cardiac septum, unspecified
Q22.0 Pulmonary valve atresia
Q24.9 Congenital malformation of heart, unspecified
Q25.0 Patent ductus arteriosus
Q28.9 Congenital malformation of circulatory system, unspecified
R00.0 Tachycardia, unspecified
R00.1 Bradycardia, unspecified
R00.2 Palpitations
R00.8 Other abnormalities of heart beat
R00.9 Unspecified abnormalities of heart beat
R01.0 Benign and innocent cardiac murmurs
R01.2 Other cardiac sounds
R06.00 Dyspnea, unspecified
R06.09 Other forms of dyspnea
R06.2 Wheezing
R06.4 Hyperventilation
R06.81 Apnea, not elsewhere classified
R06.9 Unspecified abnormalities of breathing
R07.1 Chest pain on breathing
R07.9 Chest pain, unspecified
R09.01 Asphyxia
R09.02 Hypoxemia
R09.2 Respiratory arrest
R10.11 Right upper quadrant pain
R10.12 Left upper quadrant pain
R10.13 Epigastric pain
R20.0 Anesthesia of skin
R20.9 Unspecified disturbances of skin sensation
R22.2 Localized swelling, mass and lump, trunk
R23.1 Pallor
R23.2 Flushing
R40.4 Transient alteration of awareness
R42 Dizziness and giddiness
R53.0 Neoplastic (malignant) related fatigue
R53.1 Weakness
R53.81 Other malaise
R53.83 Other fatigue
R55 Syncope and collapse
R56.00 Simple febrile convulsions
R56.9 Unspecified convulsions
R57.0 Cardiogenic shock
R57.9 Shock, unspecified
R65.10 Systemic inflammatory response syndrome (SIRS) of non-infectious origin without acute organ dysfunction
R65.21 Severe sepsis with septic shock
R94.30 Abnormal result of cardiovascular function study, unspecified
R94.39 Abnormal result of other cardiovascular function study
S26.00XA Unspecified injury of heart with hemopericardium, initial encounter
S26.99XS Other injury of heart, unspecified with or without hemopericardium, sequela
S27.0XXA Traumatic pneumothorax, initial encounter
S27.399S Other injuries of lung, unspecified, sequela
S29.001A Unspecified injury of muscle and tendon of front wall of thorax, initial encounter
S29.009S Unspecified injury of muscle and tendon of unspecified wall of thorax, sequela
S29.091A Other injury of muscle and tendon of front wall of thorax, initial encounter
S29.099S Other injury of muscle and tendon of unspecified wall of thorax, sequela
S29.8XXA Other specified injuries of thorax, initial encounter
S29.8XXS Other specified injuries of thorax, sequela
S29.9XXA Unspecified injury of thorax, initial encounter
S29.9XXS Unspecified injury of thorax, sequela
S39.001A Unspecified injury of muscle, fascia and tendon of abdomen, initial encounter
S39.003S Unspecified injury of muscle, fascia and tendon of pelvis, sequela
S39.091A Other injury of muscle, fascia and tendon of abdomen, initial encounter
S39.093S Other injury of muscle, fascia and tendon of pelvis, sequela
S39.81XA Other specified injuries of abdomen, initial encounter
S39.94XS Unspecified injury of external genitals, sequela
T36.0X5A Adverse effect of penicillins, initial encounter
T36.0X5S Adverse effect of penicillins, sequela
T36.1X5A Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter
T36.1X5S Adverse effect of cephalosporins and other beta-lactam antibiotics, sequela
T36.2X5A Adverse effect of chloramphenicol group, initial encounter
T36.2X5S Adverse effect of chloramphenicol group, sequela
T36.3X5A Adverse effect of macrolides, initial encounter
T36.3X5S Adverse effect of macrolides, sequela
T36.4X5A Adverse effect of tetracyclines, initial encounter
T36.5X5A Adverse effect of aminoglycosides, initial encounter
T36.5X5S Adverse effect of aminoglycosides, sequela
T36.6X5A Adverse effect of rifampicins, initial encounter
T36.6X5S Adverse effect of rifampicins, sequela
T36.7X5A Adverse effect of antifungal antibiotics, systemically used, initial encounter
T36.7X5S Adverse effect of antifungal antibiotics, systemically used, sequela
T36.8X5A Adverse effect of other systemic antibiotics, initial encounter
T36.8X5S Adverse effect of other systemic antibiotics, sequela
T36.95XA Adverse effect of unspecified systemic antibiotic, initial encounter
T36.95XS Adverse effect of unspecified systemic antibiotic, sequela
T37.0X5A Adverse effect of sulfonamides, initial encounter
T37.0X5S Adverse effect of sulfonamides, sequela
T37.1X5A Adverse effect of antimycobacterial drugs, initial encounter
T37.1X5S Adverse effect of antimycobacterial drugs, sequela
T37.2X5A Adverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter
T37.3X5A Adverse effect of other antiprotozoal drugs, initial encounter
T37.3X5S Adverse effect of other antiprotozoal drugs, sequela
T37.4X5A Adverse effect of anthelminthics, initial encounter
T37.4X5S Adverse effect of anthelminthics, sequela
T37.5X5A Adverse effect of antiviral drugs, initial encounter
T37.5X5S Adverse effect of antiviral drugs, sequela
T37.8X5A Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter
T37.8X5S Adverse effect of other specified systemic anti-infectives and antiparasitics, sequela
T37.95XA Adverse effect of unspecified systemic anti-infective and antiparasitic, initial encounter
T37.95XS Adverse effect of unspecified systemic anti-infective and antiparasitic, sequela
T38.0X5A Adverse effect of glucocorticoids and synthetic analogues, initial encounter
T38.0X5S Adverse effect of glucocorticoids and synthetic analogues, sequela
T38.1X5A Adverse effect of thyroid hormones and substitutes, initial encounter
T38.1X5S Adverse effect of thyroid hormones and substitutes, sequela
T38.2X5A Adverse effect of antithyroid drugs, initial encounter
T38.2X5S Adverse effect of antithyroid drugs, sequela
T38.3X5A Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter
T38.3X5S Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, sequela
T38.4X5A Adverse effect of oral contraceptives, initial encounter
T38.4X5S Adverse effect of oral contraceptives, sequela
T38.5X5A Adverse effect of other estrogens and progestogens, initial encounter
T38.5X5S Adverse effect of other estrogens and progestogens, sequela
T38.6X5A Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
T38.6X5S Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela
T38.7X5A Adverse effect of androgens and anabolic congeners, initial encounter
T38.7X5S Adverse effect of androgens and anabolic congeners, sequela
T38.805A Adverse effect of unspecified hormones and synthetic substitutes, initial encounter
T38.805S Adverse effect of unspecified hormones and synthetic substitutes, sequela
T38.815A Adverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter
T38.815S Adverse effect of anterior pituitary [adenohypophyseal] hormones, sequela
T38.895A Adverse effect of other hormones and synthetic substitutes, initial encounter
T38.895S Adverse effect of other hormones and synthetic substitutes, sequela
T38.905A Adverse effect of unspecified hormone antagonists, initial encounter
T38.905S Adverse effect of unspecified hormone antagonists, sequela
T38.995A Adverse effect of other hormone antagonists, initial encounter
T38.995S Adverse effect of other hormone antagonists, sequela
T39.015A Adverse effect of aspirin, initial encounter
T39.015S Adverse effect of aspirin, sequela
T39.095A Adverse effect of salicylates, initial encounter
T39.095S Adverse effect of salicylates, sequela
T39.1X5A Adverse effect of 4-Aminophenol derivatives, initial encounter
T39.1X5S Adverse effect of 4-Aminophenol derivatives, sequela
T39.2X5A Adverse effect of pyrazolone derivatives, initial encounter
T39.2X5S Adverse effect of pyrazolone derivatives, sequela
T39.315A Adverse effect of propionic acid derivatives, initial encounter
T39.315S Adverse effect of propionic acid derivatives, sequela
T39.395A Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
T39.395S Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela
T39.4X5A Adverse effect of antirheumatics, not elsewhere classified, initial encounter
T39.4X5S Adverse effect of antirheumatics, not elsewhere classified, sequela
T39.8X5A Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
T39.8X5S Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela
T39.95XA Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
T39.95XS Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela
T40.0X5A Adverse effect of opium, initial encounter
T40.0X5S Adverse effect of opium, sequela
T40.2X5A Adverse effect of other opioids, initial encounter
T40.2X5S Adverse effect of other opioids, sequela
T40.3X5A Adverse effect of methadone, initial encounter
T40.3X5S Adverse effect of methadone, sequela
T40.4X5A Adverse effect of other synthetic narcotics, initial encounter
T40.4X5S Adverse effect of other synthetic narcotics, sequela
T40.5X5A Adverse effect of cocaine, initial encounter
T40.5X5S Adverse effect of cocaine, sequela
T40.605A Adverse effect of unspecified narcotics, initial encounter
T40.605S Adverse effect of unspecified narcotics, sequela
T40.695A Adverse effect of other narcotics, initial encounter
T40.695S Adverse effect of other narcotics, sequela
T40.7X5A Adverse effect of cannabis (derivatives), initial encounter
T40.7X5S Adverse effect of cannabis (derivatives), sequela
T40.905A Adverse effect of unspecified psychodysleptics [hallucinogens], initial encounter
T40.905S Adverse effect of unspecified psychodysleptics [hallucinogens], sequela
T40.995A Adverse effect of other psychodysleptics [hallucinogens], initial encounter
T40.995S Adverse effect of other psychodysleptics [hallucinogens], sequela
T41.0X5A Adverse effect of inhaled anesthetics, initial encounter
T41.0X5S Adverse effect of inhaled anesthetics, sequela
T41.1X5A Adverse effect of intravenous anesthetics, initial encounter
T41.1X5S Adverse effect of intravenous anesthetics, sequela
T41.205A Adverse effect of unspecified general anesthetics, initial encounter
T41.205S Adverse effect of unspecified general anesthetics, sequela
T41.295A Adverse effect of other general anesthetics, initial encounter
T41.295S Adverse effect of other general anesthetics, sequela
T41.3X5A Adverse effect of local anesthetics, initial encounter
T41.3X5S Adverse effect of local anesthetics, sequela
T41.45XA Adverse effect of unspecified anesthetic, initial encounter
T41.45XS Adverse effect of unspecified anesthetic, sequela
T41.5X5A Adverse effect of therapeutic gases, initial encounter
T41.5X5S Adverse effect of therapeutic gases, sequela
T42.0X5A Adverse effect of hydantoin derivatives, initial encounter
T42.0X5S Adverse effect of hydantoin derivatives, sequela
T42.1X5A Adverse effect of iminostilbenes, initial encounter
T42.1X5S Adverse effect of iminostilbenes, sequela
T42.2X5A Adverse effect of succinimides and oxazolidinediones, initial encounter
T42.2X5S Adverse effect of succinimides and oxazolidinediones, sequela
T42.3X5A Adverse effect of barbiturates, initial encounter
T42.3X5S Adverse effect of barbiturates, sequela
T42.4X5A Adverse effect of benzodiazepines, initial encounter
T42.4X5S Adverse effect of benzodiazepines, sequela
T42.5X5A Adverse effect of mixed antiepileptics, initial encounter
T42.5X5S Adverse effect of mixed antiepileptics, sequela
T42.6X5A Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter
T42.6X5S Adverse effect of other antiepileptic and sedative-hypnotic drugs, sequela
T42.75XA Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter
T42.75XS Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, sequela
T42.8X5A Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
T42.8X5S Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela
T43.015A Adverse effect of tricyclic antidepressants, initial encounter
T43.015S Adverse effect of tricyclic antidepressants, sequela
T43.025A Adverse effect of tetracyclic antidepressants, initial encounter
T43.025S Adverse effect of tetracyclic antidepressants, sequela
T43.1X5A Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter
T43.1X5S Adverse effect of monoamine-oxidase-inhibitor antidepressants, sequela
T43.205A Adverse effect of unspecified antidepressants, initial encounter
T43.205S Adverse effect of unspecified antidepressants, sequela
T43.215A Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
T43.215S Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela
T43.225A Adverse effect of selective serotonin reuptake inhibitors, initial encounter
T43.225S Adverse effect of selective serotonin reuptake inhibitors, sequela
T43.295A Adverse effect of other antidepressants, initial encounter
T43.295S Adverse effect of other antidepressants, sequela
T43.3X5A Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter
T43.3X5S Adverse effect of phenothiazine antipsychotics and neuroleptics, sequela
T43.4X5A Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter
T43.4X5S Adverse effect of butyrophenone and thiothixene neuroleptics, sequela
T43.505A Adverse effect of unspecified antipsychotics and neuroleptics, initial encounter
T43.505S Adverse effect of unspecified antipsychotics and neuroleptics, sequela
T43.595A Adverse effect of other antipsychotics and neuroleptics, initial encounter
T43.595S Adverse effect of other antipsychotics and neuroleptics, sequela
T43.605A Adverse effect of unspecified psychostimulants, initial encounter
T43.605S Adverse effect of unspecified psychostimulants, sequela
T43.615A Adverse effect of caffeine, initial encounter
T43.615S Adverse effect of caffeine, sequela
T43.625A Adverse effect of amphetamines, initial encounter
T43.625S Adverse effect of amphetamines, sequela
T43.635A Adverse effect of methylphenidate, initial encounter
T43.635S Adverse effect of methylphenidate, sequela
T43.695A Adverse effect of other psychostimulants, initial encounter
T43.695S Adverse effect of other psychostimulants, sequela
T43.8X5A Adverse effect of other psychotropic drugs, initial encounter
T43.8X5S Adverse effect of other psychotropic drugs, sequela
T43.95XA Adverse effect of unspecified psychotropic drug, initial encounter
T43.95XS Adverse effect of unspecified psychotropic drug, sequela
T44.0X5A Adverse effect of anticholinesterase agents, initial encounter
T44.0X5S Adverse effect of anticholinesterase agents, sequela
T44.1X5A Adverse effect of other parasympathomimetics [cholinergics], initial encounter
T44.1X5S Adverse effect of other parasympathomimetics [cholinergics], sequela
T44.2X1A Poisoning by ganglionic blocking drugs, accidental (unintentional), initial encounter
T44.2X1S Poisoning by ganglionic blocking drugs, accidental (unintentional), sequela
T44.2X2A Poisoning by ganglionic blocking drugs, intentional self-harm, initial encounter
T44.2X2S Poisoning by ganglionic blocking drugs, intentional self-harm, sequela
T44.2X3A Poisoning by ganglionic blocking drugs, assault, initial encounter
T44.2X3S Poisoning by ganglionic blocking drugs, assault, sequela
T44.2X4A Poisoning by ganglionic blocking drugs, undetermined, initial encounter
T44.2X4S Poisoning by ganglionic blocking drugs, undetermined, sequela
T44.2X5A Adverse effect of ganglionic blocking drugs, initial encounter
T44.2X5S Adverse effect of ganglionic blocking drugs, sequela
T44.3X5A Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
T44.3X5S Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
T44.4X5A Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter
T44.4X5S Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela
T44.5X5A Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter
T44.5X5S Adverse effect of predominantly beta-adrenoreceptor agonists, sequela
T44.6X5A Adverse effect of alpha-adrenoreceptor antagonists, initial encounter
T44.6X5S Adverse effect of alpha-adrenoreceptor antagonists, sequela
T44.7X5A Adverse effect of beta-adrenoreceptor antagonists, initial encounter
T44.7X5S Adverse effect of beta-adrenoreceptor antagonists, sequela
T44.8X5A Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
T44.8X5S Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela
T44.905A Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter
T44.905S Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela
T44.995A Adverse effect of other drug primarily affecting the autonomic nervous system, initial encounter
T44.995S Adverse effect of other drug primarily affecting the autonomic nervous system, sequela
T45.0X5A Adverse effect of antiallergic and antiemetic drugs, initial encounter
T45.0X5S Adverse effect of antiallergic and antiemetic drugs, sequela
T45.1X5A Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
T45.1X5S Adverse effect of antineoplastic and immunosuppressive drugs, sequela
T45.2X5A Adverse effect of vitamins, initial encounter
T45.2X5S Adverse effect of vitamins, sequela
T45.3X5A Adverse effect of enzymes, initial encounter
T45.3X5S Adverse effect of enzymes, sequela
T45.4X5A Adverse effect of iron and its compounds, initial encounter
T45.4X5S Adverse effect of iron and its compounds, sequela
T45.515A Adverse effect of anticoagulants, initial encounter
T45.525A Adverse effect of antithrombotic drugs, initial encounter
T45.525S Adverse effect of antithrombotic drugs, sequela
T45.605A Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
T45.605S Adverse effect of unspecified fibrinolysis-affecting drugs, sequela
T45.615A Adverse effect of thrombolytic drugs, initial encounter
T45.615S Adverse effect of thrombolytic drugs, sequela
T45.625A Adverse effect of hemostatic drug, initial encounter
T45.625S Adverse effect of hemostatic drug, sequela
T45.695A Adverse effect of other fibrinolysis-affecting drugs, initial encounter
T45.695S Adverse effect of other fibrinolysis-affecting drugs, sequela
T45.7X5A Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
T45.7X5S Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
T45.8X5A Adverse effect of other primarily systemic and hematological agents, initial encounter
T45.8X5S Adverse effect of other primarily systemic and hematological agents, sequela
T45.95XA Adverse effect of unspecified primarily systemic and hematological agent, initial encounter
T45.95XS Adverse effect of unspecified primarily systemic and hematological agent, sequela
T46.0X1A Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
T46.0X5S Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
T46.1X1A Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter
T46.1X5S Adverse effect of calcium-channel blockers, sequela
T46.2X1A Poisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter
T46.2X5S Adverse effect of other antidysrhythmic drugs, sequela
T46.3X1A Poisoning by coronary vasodilators, accidental (unintentional), initial encounter
T46.3X5S Adverse effect of coronary vasodilators, sequela
T46.4X1A Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter
T46.4X5S Adverse effect of angiotensin-converting-enzyme inhibitors, sequela
T46.5X1A Poisoning by other antihypertensive drugs, accidental (unintentional), initial encounter
T46.5X5S Adverse effect of other antihypertensive drugs, sequela
T46.6X1A Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter
T46.6X5S Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
T46.7X1A Poisoning by peripheral vasodilators, accidental (unintentional), initial encounter
T46.7X5S Adverse effect of peripheral vasodilators, sequela
T46.8X1A Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter
T46.8X5S Adverse effect of antivaricose drugs, including sclerosing agents, sequela
T46.901A Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
T46.905S Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
T46.991A Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
T46.995S Adverse effect of other agents primarily affecting the cardiovascular system, sequela
T47.0X5A Adverse effect of histamine H2-receptor blockers, initial encounter
T47.0X5S Adverse effect of histamine H2-receptor blockers, sequela
T47.1X5A Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
T47.1X5S Adverse effect of other antacids and anti-gastric-secretion drugs, sequela
T47.2X5A Adverse effect of stimulant laxatives, initial encounter
T47.2X5S Adverse effect of stimulant laxatives, sequela
T47.3X5A Adverse effect of saline and osmotic laxatives, initial encounter
T47.3X5S Adverse effect of saline and osmotic laxatives, sequela
T47.4X5A Adverse effect of other laxatives, initial encounter
T47.4X5S Adverse effect of other laxatives, sequela
T47.5X5A Adverse effect of digestants, initial encounter
T47.5X5S Adverse effect of digestants, sequela
T47.6X5A Adverse effect of antidiarrheal drugs, initial encounter
T47.6X5S Adverse effect of antidiarrheal drugs, sequela
T47.7X5A Adverse effect of emetics, initial encounter
T47.7X5S Adverse effect of emetics, sequela
T47.8X5A Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter
T47.8X5S Adverse effect of other agents primarily affecting gastrointestinal system, sequela
T47.95XA Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter
T47.95XS Adverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela
T48.0X5A Adverse effect of oxytocic drugs, initial encounter
T48.0X5S Adverse effect of oxytocic drugs, sequela
T48.1X5A Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
T48.1X5S Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela
T48.205A Adverse effect of unspecified drugs acting on muscles, initial encounter
T48.205S Adverse effect of unspecified drugs acting on muscles, sequela
T48.295A Adverse effect of other drugs acting on muscles, initial encounter
T48.295S Adverse effect of other drugs acting on muscles, sequela
T48.3X5A Adverse effect of antitussives, initial encounter
T48.3X5S Adverse effect of antitussives, sequela
T48.4X5A Adverse effect of expectorants, initial encounter
T48.4X5S Adverse effect of expectorants, sequela
T48.5X5A Adverse effect of other anti-common-cold drugs, initial encounter
T48.5X5S Adverse effect of other anti-common-cold drugs, sequela
T48.6X5A Adverse effect of antiasthmatics, initial encounter
T48.6X5S Adverse effect of antiasthmatics, sequela
T48.905A Adverse effect of unspecified agents primarily acting on the respiratory system, initial encounter
T48.905S Adverse effect of unspecified agents primarily acting on the respiratory system, sequela
T48.995A Adverse effect of other agents primarily acting on the respiratory system, initial encounter
T48.995S Adverse effect of other agents primarily acting on the respiratory system, sequela
T49.0X5A Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
T49.0X5S Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela
T49.1X5A Adverse effect of antipruritics, initial encounter
T49.1X5S Adverse effect of antipruritics, sequela
T49.2X5A Adverse effect of local astringents and local detergents, initial encounter
T49.2X5S Adverse effect of local astringents and local detergents, sequela
T49.3X5A Adverse effect of emollients, demulcents and protectants, initial encounter
T49.3X5S Adverse effect of emollients, demulcents and protectants, sequela
T49.4X5A Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
T49.4X5S Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
T49.5X5A Adverse effect of ophthalmological drugs and preparations, initial encounter
T49.5X5S Adverse effect of ophthalmological drugs and preparations, sequela
T49.6X5A Adverse effect of otorhinolaryngological drugs and preparations, initial encounter
T49.6X5S Adverse effect of otorhinolaryngological drugs and preparations, sequela
T49.7X5A Adverse effect of dental drugs, topically applied, initial encounter
T49.7X5S Adverse effect of dental drugs, topically applied, sequela
T49.8X5A Adverse effect of other topical agents, initial encounter
T49.8X5S Adverse effect of other topical agents, sequela
T49.95XA Adverse effect of unspecified topical agent, initial encounter
T49.95XS Adverse effect of unspecified topical agent, sequela
T50.0X5A Adverse effect of mineralocorticoids and their antagonists, initial encounter
T50.0X5S Adverse effect of mineralocorticoids and their antagonists, sequela
T50.1X5A Adverse effect of loop [high-ceiling] diuretics, initial encounter
T50.1X5S Adverse effect of loop [high-ceiling] diuretics, sequela
T50.2X5A Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
T50.2X5S Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
T50.3X5A Adverse effect of electrolytic, caloric and water-balance agents, initial encounter
T50.3X5S Adverse effect of electrolytic, caloric and water-balance agents, sequela
T50.4X5A Adverse effect of drugs affecting uric acid metabolism, initial encounter
T50.4X5S Adverse effect of drugs affecting uric acid metabolism, sequela
T50.5X5A Adverse effect of appetite depressants, initial encounter
T50.5X5S Adverse effect of appetite depressants, sequela
T50.6X5A Adverse effect of antidotes and chelating agents, initial encounter
T50.6X5S Adverse effect of antidotes and chelating agents, sequela
T50.7X5A Adverse effect of analeptics and opioid receptor antagonists, initial encounter
T50.7X5S Adverse effect of analeptics and opioid receptor antagonists, sequela
T50.8X5A Adverse effect of diagnostic agents, initial encounter
T50.8X5S Adverse effect of diagnostic agents, sequela
T50.905A Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter
T50.905S Adverse effect of unspecified drugs, medicaments and biological substances, sequela
T50.995A Adverse effect of other drugs, medicaments and biological substances, initial encounter
T50.995S Adverse effect of other drugs, medicaments and biological substances, sequela
T50.A15A Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter
T50.A15S Adverse effect of pertussis vaccine, including combinations with a pertussis component, sequela
T50.A25A Adverse effect of mixed bacterial vaccines without a pertussis component, initial encounter
T50.A25S Adverse effect of mixed bacterial vaccines without a pertussis component, sequela
T50.A95A Adverse effect of other bacterial vaccines, initial encounter
T50.A95S Adverse effect of other bacterial vaccines, sequela
T50.B15A Adverse effect of smallpox vaccines, initial encounter
T50.B15S Adverse effect of smallpox vaccines, sequela
T50.B95A Adverse effect of other viral vaccines, initial encounter
T50.Z15A Adverse effect of immunoglobulin, initial encounter
T50.Z15S Adverse effect of immunoglobulin, sequela
T50.Z95A Adverse effect of other vaccines and biological substances, initial encounter
T50.Z95S Adverse effect of other vaccines and biological substances, sequela
T51.0X1A Toxic effect of ethanol, accidental (unintentional), initial encounter
T65.94XS Toxic effect of unspecified substance, undetermined, sequela
T78.00XA Anaphylactic reaction due to unspecified food, initial encounter
T78.8XXS Other adverse effects, not elsewhere classified, sequela
T81.718A Complication of other artery following a procedure, not elsewhere classified, initial encounter
T81.718S Complication of other artery following a procedure, not elsewhere classified, sequela
T81.719A Complication of unspecified artery following a procedure, not elsewhere classified, initial encounter
T81.719S Complication of unspecified artery following a procedure, not elsewhere classified, sequela
T81.72XA Complication of vein following a procedure, not elsewhere classified, initial encounter
T81.72XS Complication of vein following a procedure, not elsewhere classified, sequela
T82.01XA Breakdown (mechanical) of heart valve prosthesis, initial encounter
T82.228S Other mechanical complication of biological heart valve graft, sequela
T82.512A Breakdown (mechanical) of artificial heart, initial encounter
T82.512S Breakdown (mechanical) of artificial heart, sequela
T82.514A Breakdown (mechanical) of infusion catheter, initial encounter
T82.514S Breakdown (mechanical) of infusion catheter, sequela
T82.518A Breakdown (mechanical) of other cardiac and vascular devices and implants, initial encounter
T82.518S Breakdown (mechanical) of other cardiac and vascular devices and implants, sequela
T82.519A Breakdown (mechanical) of unspecified cardiac and vascular devices and implants, initial encounter
T82.519S Breakdown (mechanical) of unspecified cardiac and vascular devices and implants, sequela
T82.522A Displacement of artificial heart, initial encounter
T82.522S Displacement of artificial heart, sequela
T82.524A Displacement of infusion catheter, initial encounter
T82.524S Displacement of infusion catheter, sequela
T82.528A Displacement of other cardiac and vascular devices and implants, initial encounter
T82.528S Displacement of other cardiac and vascular devices and implants, sequela
T82.529A Displacement of unspecified cardiac and vascular devices and implants, initial encounter
T82.529S Displacement of unspecified cardiac and vascular devices and implants, sequela
T82.532A Leakage of artificial heart, initial encounter
T82.532S Leakage of artificial heart, sequela
T82.534A Leakage of infusion catheter, initial encounter
T82.534S Leakage of infusion catheter, sequela
T82.538A Leakage of other cardiac and vascular devices and implants, initial encounter
T82.538S Leakage of other cardiac and vascular devices and implants, sequela
T82.539A Leakage of unspecified cardiac and vascular devices and implants, initial encounter
T82.539S Leakage of unspecified cardiac and vascular devices and implants, sequela
T82.592A Other mechanical complication of artificial heart, initial encounter
T82.592S Other mechanical complication of artificial heart, sequela
T82.594A Other mechanical complication of infusion catheter, initial encounter
T82.594S Other mechanical complication of infusion catheter, sequela
T82.598A Other mechanical complication of other cardiac and vascular devices and implants, initial encounter
T82.598S Other mechanical complication of other cardiac and vascular devices and implants, sequela
T82.599A Other mechanical complication of unspecified cardiac and vascular devices and implants, initial encounter
T82.599S Other mechanical complication of unspecified cardiac and vascular devices and implants, sequela
T86.00 Unspecified complication of bone marrow transplant
T86.819 Unspecified complication of lung transplant
T86.830 Bone graft rejection
T86.839 Unspecified complication of bone graft
T86.850 Intestine transplant rejection
T86.99 Other complications of unspecified transplanted organ and tissue
T88.2XXA Shock due to anesthesia, initial encounter
T88.2XXS Shock due to anesthesia, sequela
T88.3XXA Malignant hyperthermia due to anesthesia, initial encounter
T88.3XXS Malignant hyperthermia due to anesthesia, sequela
T88.51XA Hypothermia following anesthesia, initial encounter
T88.51XS Hypothermia following anesthesia, sequela
T88.52XA Failed moderate sedation during procedure, initial encounter
T88.52XS Failed moderate sedation during procedure, sequela
T88.59XA Other complications of anesthesia, initial encounter
T88.59XS Other complications of anesthesia, sequela
T88.6XXA Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered, initial encounter
T88.6XXS Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered, sequela
Z01.810 Encounter for preprocedural cardiovascular examination
Z51.81 Encounter for therapeutic drug level monitoring
Z79.3 Long term (current) use of hormonal contraceptives
Z79.891 Long term (current) use of opiate analgesic
Z79.899 Other long term (current) drug therapy
Z95.0 Presence of cardiac pacemaker
Z95.1 Presence of aortocoronary bypass graft
Z95.5 Presence of coronary angioplasty implant and graft
Z95.810 Presence of automatic (implantable) cardiac defibrillator
Z95.818 Presence of other cardiac implants and grafts
Z98.61 Coronary angioplasty status
M1A.10X0 Lead-induced chronic gout, unspecified site, without tophus (tophi)
T37.2X5S Adverse effect of antimalarials and drugs acting on other blood protozoa, sequela

No comments:

Post a Comment